Featured Research

from universities, journals, and other organizations

Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow

Date:
November 12, 2013
Source:
University of Michigan Health System
Summary:
Big name athletes have reportedly used PRP therapy for sports injuries. Does it work?

A procedure intended to help heal musculoskeletal injuries called platelet-rich plasma therapy, or P.R.P., has created a big buzz in sports medicine and the media in recent years. Tiger Woods reportedly received the procedure for a sore knee and Pittsburgh Steelers' Hines Ward used it for a sprained knee ligament just before playing a key role in the team's 2009 Super Bowl victory.

Related Articles


However, the method -- which involves concentrating the platelets in a patient's blood sample and re-injecting them into the injured area to boost the body's own healing powers -- is expensive and rarely covered by insurance because it lacks scientific research to back it up.

Researchers at the University of Michigan are taking a step towards answering some questions about the therapy through a new clinical trial exploring how PRP specifically affects tennis elbow (or lateral epicondylitis). People with this condition experience pain from injury and degeneration in the tendon along the outside of the elbow, especially with extending the wrist. It can be caused by overuse or sports related repetitive strain.

"The popularity of PRP has moved faster than the science," says principal investigator Jon Jacobson, M.D., U-M Musculoskeletal Division Director and Professor of Radiology in the U-M Medical School. "Tennis elbow can be a debilitating condition, and the goal of the study is determine whether symptoms are improved in people who receive PRP injections compared to those who receive alternative and much cheaper types of treatment."

Other treatments for tennis elbow, such as corticosteroid injection, have shown little long-term success.

Researchers will compare the effects of physical therapy alone versus physical therapy in conjunction with either dry needle tendon fenestration (needling the tendon to make it bleed and to induce healing), re-injection of a patient's venous blood, or re-injection of the concentrated platelet-rich layer of a patient's own blood (PRP). This trial is unique in that it is a blind study (which means participants don't know which arm of the study they're in, preventing false positive experiences based on the placebo effect) to specifically compare PRP outcomes to other forms of treatment.

"PRP injection has emerged as a treatment alternative for many musculoskeletal conditions and recently been popularized by the media because of its use among well-known athletes -- however it costs more than other options and success stories have yet to be properly grounded in science," Jacobson says.

"If we find that platelet rich plasma is better compared to the other treatments, it would justify the high cost and growing industry associated with the procedure."


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow." ScienceDaily. ScienceDaily, 12 November 2013. <www.sciencedaily.com/releases/2013/11/131112141239.htm>.
University of Michigan Health System. (2013, November 12). Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2013/11/131112141239.htm
University of Michigan Health System. "Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow." ScienceDaily. www.sciencedaily.com/releases/2013/11/131112141239.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Raw: Paralyzed Marine Walks With Robotic Braces

Raw: Paralyzed Marine Walks With Robotic Braces

AP (Nov. 21, 2014) Marine Corps officials say a special operations officer left paralyzed by a sniper's bullet in Afghanistan walked using robotic leg braces in a ceremony to award him a Bronze Star. (Nov. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins